Cord blood-derived T cell receptor natural killer (TCR NK) platform offers potential for scalable off-the-shelf cell therapy HOUSTON, SAN DIEGO and LONDON ― The University of Texas MD Anderson Cancer Center and Replay today announced the launch of Syena, a new oncology-focused product company pioneering […]



